Analysts Set Neighbourly Pharmacy Inc. (TSE:NBLY) PT at C$20.93

Neighbourly Pharmacy Inc. (TSE:NBLYGet Free Report) has been assigned an average rating of “Hold” from the five research firms that are currently covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is C$20.93.

A number of brokerages have recently issued reports on NBLY. National Bankshares cut their price target on shares of Neighbourly Pharmacy from C$20.50 to C$18.50 and set a “tender” rating for the company in a report on Monday, January 15th. TD Securities cut Neighbourly Pharmacy from an “outperform” rating to a “sector perform” rating and cut their target price for the stock from C$28.00 to C$18.50 in a research note on Wednesday, February 14th. Finally, Desjardins decreased their price target on Neighbourly Pharmacy from C$20.00 to C$18.50 and set a “hold” rating on the stock in a research note on Wednesday, February 14th.

Get Our Latest Report on NBLY

Neighbourly Pharmacy Stock Up 0.3 %

NBLY stock opened at C$18.60 on Friday. The company has a current ratio of 1.14, a quick ratio of 0.75 and a debt-to-equity ratio of 58.29. The firm has a 50-day moving average of C$18.45 and a two-hundred day moving average of C$17.50. Neighbourly Pharmacy has a 12 month low of C$12.05 and a 12 month high of C$23.00. The company has a market cap of C$835.51 million, a price-to-earnings ratio of -25.48 and a beta of 0.29.

Insider Buying and Selling at Neighbourly Pharmacy

In related news, Senior Officer Stephen Richard Losty sold 3,033 shares of the stock in a transaction on Wednesday, February 14th. The shares were sold at an average price of C$18.36, for a total value of C$55,685.88. In related news, Senior Officer Stephen Richard Losty sold 3,033 shares of the company’s stock in a transaction dated Wednesday, February 14th. The stock was sold at an average price of C$18.36, for a total value of C$55,685.88. Also, insider Rx Sidecar GP Inc. purchased 62,500 shares of the business’s stock in a transaction on Monday, March 11th. The shares were purchased at an average cost of C$18.53 per share, for a total transaction of C$1,158,350.00. 0.55% of the stock is currently owned by insiders.

About Neighbourly Pharmacy

(Get Free Report

Neighbourly Pharmacy Inc owns and operates a chain of retail pharmacies in Canada. The company sells prescription medication, confections and food, over the counter drugs, and health and beauty aids. It operates pharmacies under the various banners, such as IDA/Guardian, Pharmachoice, Pharmasave, Remedy's RX, and Drug Trading.

See Also

Analyst Recommendations for Neighbourly Pharmacy (TSE:NBLY)

Receive News & Ratings for Neighbourly Pharmacy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neighbourly Pharmacy and related companies with MarketBeat.com's FREE daily email newsletter.